Business Context and Reporting Period
This Form 8-K Current Report was filed by Pacific Biosciences of California, Inc. (PACB) on July 8, 2026. The report discloses a corporate governance event regarding the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
On July 8, 2026, Christopher M. Smith resigned from the Board of Directors, effective immediately. The Company stated it is not aware of any disagreement between Mr. Smith and the Company regarding operations, policies, or practices that resulted in the resignation.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the immediate departure of the director.
Investor Verification Checklist
- Confirm the effective date of Christopher M. Smith's resignation (July 8, 2026).
- Verify the Company's statement that no disagreement existed regarding the resignation.
- Check for subsequent filings regarding the appointment of a replacement director.